Dr. Raphael Nir
Dr. Nir is a scientist, entrepreneur and angel investor with over 26 years of experience commercializing recombinant cytokines and pre-clinical contract research services. Dr. Nir is the co-founder of two pre-clinical contract research organizations; SBH Sciences and Woodland Biosciences and three biotechnology companies: Karyopharm Therapeutics (NASDAQ: KPTI), Galectin Sciences and Alma Bio Therapeutics. Dr. Nir is also the co-founder of SBH Diagnostics and the co-founder and partner at Sky Ventures.
He received his PhD from Tel-Aviv University (Biotechnology; 1990) and Master in Management (1997; NJIT). Since 1997, Dr. Nir serves as the President and CSO of SBH Sciences where he manages all company's R&D and business activities.